Anchorsure Versus Capio for Sacrospinous Ligament Fixation
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03565640 |
|
Recruitment Status :
Completed
First Posted : June 21, 2018
Last Update Posted : March 7, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Postoperative Pain | Device: Capio Slim Device Device: Anchorsure Device | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 48 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Participant) |
| Masking Description: | Participants and research staff will be masked during the study as much as possible, however there will be a description of the type of sacrospinous ligament fixation device used within the body of the operative note for each patient that research staff could gain access to |
| Primary Purpose: | Supportive Care |
| Official Title: | Randomized Trial Comparing Anchorsure® Suture Anchoring System and the CapioTM Slim Suture Capturing Device for Sacrospinous Ligament Suspension. |
| Actual Study Start Date : | October 29, 2018 |
| Actual Primary Completion Date : | January 26, 2022 |
| Actual Study Completion Date : | January 26, 2022 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Capio Slim Device
Participants will be randomized to the sacrospinous ligament fixation with use of Capio Slim Device
|
Device: Capio Slim Device
Participants who have been assigned to sacrospinous ligament fixation for pelvic organ prolapse will have sacrospinous ligament fixation performed with the Capio Slim Device. |
|
Experimental: Anchorsure Device
Participants will be randomized to the sacrospinous ligament fixation with use of Anchorsure Device
|
Device: Anchorsure Device
Participants who have been assigned to sacrospinous ligament fixation for pelvic organ prolapse will have sacrospinous ligament fixation performed with the Anchorsure Device. |
- Change in Buttock and Posterior Thigh Pain [ Time Frame: postoperative day 1, 7, week 6, and 12 month ]This will be assessed using the numeric rating scale (NRS). The score is 0-10, with higher scores denoting a greater degree of pain.
- Surgical Anatomic Success [ Time Frame: at week 6 ]POP-Q assessment will be performed with surgical success being defined as apical descent less than 50% of total vaginal length.
- Surgeon satisfaction [ Time Frame: postoperative day 0 ]Surgeon satisfaction with application of surgical device will be assessed via a 5-point rating scale (very dissatisfied, somewhat dissatisfied, neutral, satisfied, very satisfied).
- Surgical efficiency [ Time Frame: intraoperative ]Surgical efficiency will be assessed as continuous data measured as a means in minutes.
- Symptomatic success- PFDI-20 [ Time Frame: at week 6, and 12 month postoperative ]Symptomatic success will be assessed by the pelvic floor disability index (PFDI-20) questionnaire. The PFDI-20 has 20 items within 3 scales of symptoms (total of 20 items). Each item produces a response of 0 to 4, the average response in each scale is multiplied by 25 to obtain the scale score (range 0 to 100). The total score is the sum of the three scale score with a range of 0-300. Higher values indicate a greater degree of bother.
- Symptomatic success- PFIQ-7 [ Time Frame: at week 6, and 12 month postoperative ]Symptomatic success will be assessed by the pelvic floor impact (PFIQ-7) questionnaire. The PFIQ-7 has 7 items for each of 3 scales (total of 21 items). Each item produces a response of 0 to 3, the average response in each scale is multiplied by 100/3 to obtain the scale score (range 0 to 100). The total score is the sum of the three scale score with a range of 0-300. Higher values indicate a greater degree of bother.
- Change in Postoperative general pelvic pain [ Time Frame: postoperative day 1, 7, week 6, and 12 month ]This will be assessed using the numeric rating scale (NRS). The score is 0-10, with higher scores denoting a greater degree of pain
- Postoperative post-hospitalization opioid use [ Time Frame: postoperative day 7 ]Patients will be given a diary to record the amount of opioid pain medications they use at home after their procedure until day 7. The cumulative dose of pain medication will be converted into morphine equivalents for analysis.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 21 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | Female |
| Gender Based Eligibility: | Yes |
| Gender Eligibility Description: | Must have biological female reproductive organs. |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Female patients
- At least 21 years of age
- Surgical plan that includes a native tissue vaginal repair with apical support via sacrospinous ligament fixation. We will permit both hysteropexy and post-hysterectomy sacrospinous ligament suspension
- Understanding and acceptance of the need to return for the 6 week follow-up visit
- English speaking and able to give informed consent
- Willing and able to complete all study questionnaires
- Ambulatory
Exclusion Criteria:
- Prior sacrospinous ligament fixation procedure.
- Any serious disease or chronic condition that could interfere with the study compliance
- Inability to give informed consent
- Pregnancy or planning pregnancy prior to the 6 week postoperative visit
- Prior pelvic radiation
- Incarcerated
- Prior augmented (synthetic mesh, autologous graft, xenograft, allograft) prolapse repair
- History of significant buttock or leg pain in the past 3 months
- History of fibromyalgia, polymyositis, dermatomyositis, systemic lupus erythematosus, or other auto-immune myalgic conditions
- Current regular opioid drug therapy for any chronic pain condition
- History of loss of motor or sensory function of the lower extremities
- History of sacral decubitus ulcers
- Planned concomitant levatorplasty; anal sphincteroplasty, anal fissurectomy, rectopexy, or hemorrhoidectomy
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03565640
| United States, North Carolina | |
| Wake Forest Baptist Medical Center | |
| Winston-Salem, North Carolina, United States, 27157 | |
| Principal Investigator: | Catherine Matthews, MD | Wake Forest University Health Sciences |
Documents provided by Wake Forest University Health Sciences:
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Wake Forest University Health Sciences |
| ClinicalTrials.gov Identifier: | NCT03565640 |
| Other Study ID Numbers: |
IRB00051211 |
| First Posted: | June 21, 2018 Key Record Dates |
| Last Update Posted: | March 7, 2022 |
| Last Verified: | September 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | De-Identified data from the study will be kept on password protected digital storage for at least three years following the project completion. |
| Supporting Materials: |
Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR) Analytic Code |
| Time Frame: | At least 3 years from study completion |
| Access Criteria: | Contact the principal investigator Dr. Catherine Matthews |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | Yes |
| Product Manufactured in and Exported from the U.S.: | Yes |
|
Buttock pain Thigh pain Sacrospinous ligament fixation |
|
Pain, Postoperative Postoperative Complications Pathologic Processes Pain Neurologic Manifestations |

